Catalyst Partners Acquisition Corp. Announces Pricing of $300 Million Initial Public Offering
May 18, 2021 00:32 ET | Source: Catalyst Partners Acquisition Corp. Catalyst Partners Acquisition Corp. Cambridge, Massachusetts, UNITED STATES
SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) Catalyst Partners Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Stock Market, LLC (“Nasdaq”) and will trade under the ticker symbol “CPARU” beginning May 18, 2021. Each unit consists of one Class A ordinary share of the Company and one-fifth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are
Ann Fudge a champion for diversity, inclusion
Tuesday March 16 2021
Ann Fudge, the first African American to head a global network of marketing communication companies. PHOTO | POOL
By JOE OTIN
Women don’t want any favours from their male counterparts when it comes to career opportunities.
Neither do they need to make any excuses, in a business setting, about their greater sense of family and community.
Women don’t want any favours from their male counterparts when it comes to career opportunities. Neither do they need to make any excuses, in a business setting, about their greater sense of family and community.
Dean Nitin Nohria welcomed more than 2,500 participants to the June 11 event led by Senior Lecturers Andy Zelleke and Tony Mayo. Following the Dean’s introduction, HBS alumni, staff, and students Mia Mends (MBA 2003), George Ellis (MBA 1984), HBS CIO Ron Chandler, Chichi Anyoku (MPP/MBA 2021), Ronnie Wimberley (MBA 2021), Priyanka Chaurasia (MBA 2021), and Mike Klain (JD/MBA 2022) shared their lived experiences in reaction to and in reflection of the murders of George Floyd, Breonna Taylor, Ahmaud Arbery, Tony McDade, and those before them.
Walking into Harvard Business School as friends, roommates, and colleagues in 2017, Henri Pierre-Jacques (MBA 2019) and Jarrid Tingle (MBA 2019) already knew each other well. What they didn’t know yet was how their angel syndicate, Harlem Capital, would grow, evolve, and change the face of entrepreneurship over the next two years and beyond.
13 1Refers to continuing operations as defined on page 43 of the Condensed Financial Report, excludes Alcon, includes the businesses of Innovative Medicines and Sandoz, as well as the continuing corporate functions. 2Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 55 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.
3 Please see detailed guidance assumptions on page 8 including the forecast assumption that we see a continuation of the return to normal global healthcare systems including prescription dynamics by mid 2021. In addition, we assume that no Gilenyaand noSandostatinLAR generics enter in 2021 in the US.
Novartis International AG: Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.
Pharmaceuticals BU grew 5% (cc) driven by
Entresto (+44% cc),
Cosentyx (+13% cc),
Xiidra acquisition (+95% cc)
Promacta/Revolade (+23% cc),
Piqray (reaching USD 0.3 billion)
Sandoz sales were in line (cc, -1% USD), with Biopharmaceuticals growing 19% (cc)
COVID-19 negatively impacted demand, particularly: ophthalmology, dermatology and Sandoz retail
Core operating income² grew 13% (cc, +9% USD) and Innovative Medicines and Sandoz core margin improved to 35% and 24% of sales respectively, driven by sales growth, lower spend and productivity
Continued transformation of Manufacturing and Business Services contributing to core margin expansion